Visiogen, Inc. Garners $40,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0cb58a60-3209-40b8-8884-18f10b9a59c6&Preview=1 -
Date
4/27/2009 -
Company Name
Visiogen, Inc. -
Mailing Address
2 Goodyear Irvine, CA 92618 -
Company Description
Visiogen, Inc. is focused on developing innovative products for cataract and refractive patients. Founded in Irvine, California, in 2001, Visiogen’s first commercial application, Synchrony®, a dual-optic intraocular lens and pre-loaded injector, is currently in clinical studies in the U.S. and recently received a CE Mark in Europe. -
Website
http://www.visiogen.com -
Transaction Type
Venture Equity -
Transaction Amount
$40,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
“The funds we have raised will give us the flexibility and resources necessary to maximize the commercial impact of the Synchrony IOL,” said Reza Zadno, CEO and Founder of Visiogen, Inc. -
M&A Terms
-
Venture Investor
Novartis -
Venture Investor
Three Arch Partners -
Venture Investor
Technology Partners -
Venture Investor
New Leaf Venture Partners -
Venture Investor
Prospect Venture Partners -
Venture Investor
CMEA Ventures -
Venture Investor
Foundation Medical Partners
